Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

By April 20, 2018

MF59 adjuvanted, quadrivalent influenza vaccine (aQIV) was found to be more efficacious in preventing influenza than a non-adjuvanted conventional influenza vaccine in children aged 6 through 23 months.

Review: Treatment Recommendations for Biological Disasters

By April 17, 2018

The Centers for Disease Control and Prevention (CDC) classifies key biological agents into three categories: A, B, and C.

Personalized Cancer Vaccine Looks Promising in Early Study

By April 12, 2018

The researchers enrolled 25 platinum-pretreated, immunotherapy-naïve patients with recurrent advanced epithelial ovarian cancer (EOC) for the trial.

A Zika vaccine could virtually eliminate prenatal infections

April 11, 2018

Zika virus shown to be of moderate to high efficacy in eliminating prenatal infections.

Stronger Recommendations by PCPs for Herpes Zoster Vaccination Needed, Says Study

By April 09, 2018

From January to March 2017, the researchers distributed a cross-sectional online survey to all physicians in the Division of General Internal Medicine and Clinical Innovation at NYULH, across 5 different practice settings. A total of 138 (out of 530) responded (26%).

MenACWY-TT Vaccine Evaluated in Patients With Anatomic/Functional Asplenia

By April 09, 2018

Risk of meningococcal disease up in patients with anatomic/functional asplenia.

Herpes Zoster in Healthy Children Linked to Varicella-Zoster Vaccination

By April 05, 2018

Each of the 7 children received varicella zoster vaccination between 12 and 14 months of age.

Zika Vaccine Could Essentially Eliminate Prenatal Infection

April 03, 2018

The researchers found that for a base-case vaccine efficacy of 75% and vaccination coverage of 90%, immunizing females aged 9 to 49 years would reduce the incidence of prenatal infections by at least 94%, depending on the country-specific Zika attack rate.

Recombinant Influenza Vaccine Found to Be Safe in Children

April 02, 2018

The researchers found that both vaccines were well tolerated in both 6- to 8-year-olds and 9- to 17-year-olds. There were no vaccine-related adverse events in the 6 months of follow-up.

Children With ASD, Younger Siblings Are Undervaccinated

March 28, 2018

Vaccination rates were significantly lower among younger siblings of children with ASD

Vaccine-Derived Protection Against Mumps May Deteriorate

March 22, 2018

The researchers found that vaccine-derived immune protection against mumps waned on average 27 years after vaccination. There was no evidence of heterologous virus genotypes contributing to changes in vaccine effectiveness over time.

Compliance-linked incentives increase infant immunizations rates in rural India

March 14, 2018

Infantile immunization rates were higher among children whose caregivers received compliance-linked incentives when compared to those who received only mobile phone reminders and those who received no intervention.

Impact of Bundled Interventions Examined for Increasing HPV Vaccination Rates

March 14, 2018

The researchers observed an increase in captured opportunities for HPV vaccination, from 46.9 to 63.3%. Centerline shift demonstrated special cause, with 8 consecutive points above the preintervention mean.

Maternal Use of TDF Doesn't Further Reduce HBV Transmission

March 08, 2018

Findings in setting with low HBV transmission with administration of hepatitis B immune globulin, vaccine

Does Cumulative Vaccine Exposure in Infants Raise Risk of Certain Infections?

March 07, 2018

The matched odds ratio for estimated cumulative antigen exposure through 23 months was not significant among children with versus those without non-vaccine-targeted infections from 24 through 47 months of age.

Vaccination Outcomes of HPV Primary Care Intervention Examined

March 06, 2018

A greater effect of the intervention was seen for pediatric practices versus family medicine practices and in private practices versus public ones. According to reports from health care professionals, the most used and useful intervention components were communication training and the fact sheets.

Vaccination Coverage Among U.S.- vs. Foreign-Born Adolescents Examined

By March 02, 2018

For hepatitis B (≥3 doses), foreign-born adolescents had significantly lower coverage rates, 89.6% vs. 92.6% for U.S.-born adolescents, even after adjustments were made for demographic and socioeconomic factors.

CDC: Limited Availability of Alternative Yellow Fever Vaccine

By March 01, 2018

As part of the investigational new drug program, only a limited number of clinics can stock Stamaril.

Tourist With Measles May Have Exposed Others, Says NY State Dept of Health

By February 27, 2018

A tourist from Australia has been confirmed to have measles.

ACIP Votes in Favor of Intranasal Flu Vaccine Flumist Quadrivalent

By February 22, 2018

The Advisory Committee on Immunization Practices (ACIP) has voted in favor of a renewed recommendation for the use of Flumist Quadrivalent (Influenza Vaccine Live, Intranasal).

ACIP Recommends Use of Heplisav-B for Hepatitis B Prevention in Adults

By February 21, 2018

The Advisory Committee on Immunization Practices (ACIP) voted unanimously in favor of including Heplisav-B on its list of ACIP recommended products.

Vaccination During Pregnancy Not Linked to Infant Hospitalization, Death

February 21, 2018

There was no correlation between infant hospitalization and maternal influenza (adjusted odds ratio, 1; 95% confidence interval, 0.96 to 1.04) or Tdap (adjusted odds ratio, 0.94; 95% confidence interval, 0.88 to 1.01) vaccinations.

CDC: Elevated Flu Activity Expected to Continue for Several More Weeks

By February 16, 2018

So far this season, influenza A(H3N2) viruses have predominated, but other influenza viruses are also circulating.

Researchers Hope to Test Heroin Vaccine in Humans Soon

By February 14, 2018

Researchers investigated 20 different carrier protein/adjuvant combinations.

Conspiracy Beliefs and Anti-Vaccination Attitudes: What's the Link?

By February 07, 2018

Incidences of measles, mumps and pertussis have increased in the U.S. for the first time in a century (WHO, 2017). To identify the 'attitude roots' of vaccine rejection, a survey was issued online and completed by 5,323 usable participants in 24 different countries.

ACIP: 2018 Recommended Immunization Schedule for Adults Released

By February 06, 2018

Changes in the 2018 adult immunization schedule from the previous year's schedule include new ACIP recommendations for the use of recombinant zoster vaccine (RZV) for adults aged 50 years or older and the use of an additional dose of measles, mumps, and rubella vaccine (MMR) in a mumps outbreak setting.

ACIP: 2018 Immunization Schedule for Children, Adolescents Available

By February 06, 2018

The recommended childhood and adolescent immunization schedules for 2018 have been approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC), the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.

New Formulation of HyperRAB Approved for Rabies Post-Exposure Prophylaxis

By February 06, 2018

Reduced volume of medication offers potential for fewer injections.

Patient Portal Messages, IVR Calls May Improve Flu Vaccination Rates

By February 05, 2018

Results found that among portal users, 14% (702/5,000) of portal and IVR call recipients received EHR-documented influenza vaccines.

ACIP: Updated Recommendations for Mumps Vaccination

By January 16, 2018

The purpose of the recommendation is to improve protection of persons in outbreak settings against mumps disease and complications